These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9106767)

  • 1. D1-D2 dopamine receptor interaction: an in vivo single unit electrophysiological study.
    Murer MG; Riquelme LA; Tseng KY; Cristal A; Santos J; Pazo JH
    Neuroreport; 1997 Feb; 8(3):783-7. PubMed ID: 9106767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
    Ruskin DN; Bergstrom DA; Walters JR
    J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia.
    Waszczak BL; Martin LP; Finlay HE; Zahr N; Stellar JR
    J Pharmacol Exp Ther; 2002 Mar; 300(3):850-61. PubMed ID: 11861790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
    Abercrombie ED; DeBoer P
    J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia nigra pars reticulata units in 6-hydroxydopamine-lesioned rats: responses to striatal D2 dopamine receptor stimulation and subthalamic lesions.
    Tseng KY; Riquelme LA; Belforte JE; Pazo JH; Murer MG
    Eur J Neurosci; 2000 Jan; 12(1):247-56. PubMed ID: 10651879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH; Starr MS
    Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393.
    Ruskin DN; Rawji SS; Walters JR
    J Pharmacol Exp Ther; 1998 Jul; 286(1):272-81. PubMed ID: 9655869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine enhances glutamate-induced excitation of rat striatal neurons by cooperative activation of D1 and D2 class receptors.
    Hu XT; White FJ
    Neurosci Lett; 1997 Mar; 224(1):61-5. PubMed ID: 9132692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
    Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR
    Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.
    Keefe KA; Gerfen CR
    Neuroscience; 1995 Jun; 66(4):903-13. PubMed ID: 7651617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Stepholidine acts as a D1 partial agonist on firing activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine-lesioned rats.
    Sun BC; Zhang XX; Jin GZ
    Life Sci; 1996; 59(4):299-306. PubMed ID: 8761001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS; Joyce JN
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-administration of dopamine D1 and D2 agonists additively decreases daily food intake, body weight and hypothalamic neuropeptide Y level in rats.
    Kuo DY
    J Biomed Sci; 2002; 9(2):126-32. PubMed ID: 11914579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors.
    Abraini JH; Fechtali T; Rostain JC
    Neuroscience; 1992 Sep; 50(2):395-402. PubMed ID: 1359460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.